Table 2 Correlation between DNAJB11 expression and clinicopathological characteristics
From: Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway
Variable | DNAJB11 expression | Total | χ2 | P-value | |
|---|---|---|---|---|---|
Low | High | ||||
Age (years) | Â | Â | Â | 0.461 | 0.497 |
  ≤ 60 | 17 | 21 | 38 |  |  |
  > 60 | 24 | 22 | 46 |  |  |
Sex | Â | Â | Â | 2.001 | 0.157 |
 Female | 12 | 19 | 31 |  |  |
 Male | 29 | 24 | 53 |  |  |
Grade | Â | Â | Â | 3.221 | 0.073 |
 I/II | 33 | 27 | 60 |  |  |
 III | 8 | 16 | 24 |  |  |
Tumor sizes (cm) | Â | Â | Â | 5.777 | 0.016 |
  < 5 | 22 | 12 | 34 |  |  |
  ≥ 5 | 19 | 31 | 50 |  |  |
T stage | Â | Â | Â | 3.717 | 0.054 |
 T1/T2 | 18 | 29 | 47 |  |  |
 T3/T4 | 22 | 15 | 37 |  |  |
N stage | Â | Â | Â | Â | Â |
 N0 | 24 | 25 | 48 | 0.009 | 0.092 |
 N1/N2 | 18 | 18 | 36 |  |  |
M stage | Â | Â | Â | Â | Â |
 M0 | 40 | 43 | 83 |  | 0.488 |
 M1 | 1 | 0 | 1 |  |  |